MIRA INFORM REPORT

 

 

Report Date :

24.03.2012

 

IDENTIFICATION DETAILS

 

Name :

STERANCO HEALTHCARE PRIVATE LIMITED

 

 

Registered Office :

Medley House, D-2, MIDC Area, 10th Road, Andheri (East), Mumbai – 400093, Maharashtra

 

 

Country :

India

 

 

Financials (as on) :

31.03.2011

 

 

Date of Incorporation :

12.08.1997

 

 

Com. Reg. No.:

11-110023

 

 

Capital Investment / Paid-up Capital :

Rs.7.000 Millions

 

 

CIN No.:

[Company Identification No.]

U33110MH1997PTC110023

 

 

TAN No.:

[Tax Deduction & Collection Account No.]

MUMS23047D

 

 

Legal Form :

Private Limited Liability Company

 

 

Line of Business :

Supplier of Pharmaceutical Formulations

 

 

No. of Employees :

Not Available

 

 

RATING & COMMENTS

 

MIRA’s Rating :

Ca (23)

 

RATING

STATUS

PROPOSED CREDIT LINE

11-25

Ca

Adverse factors are apparent. Repayment of interest and principal sums in default or expected to be in default upon maturity

Limited with full security

 

Status :

Moderate

 

 

Payment Behaviour :

Slow

 

 

Litigation :

Clear

 

 

Comments :

Subject is an established company having moderate track. There appears huge accumulated losses recorded by the company. However, trade relations are reported as fair. Business is active. Payments are reported to be slow.

 

The company can be considered for business dealings with some caution.

 

NOTES :

Any query related to this report can be made on e-mail : infodept@mirainform.com while quoting report number, name and date.

 

 

ECGC Country Risk Classification List – September 30, 2011

 

Country Name

Previous Rating

(30.06.2011)

Current Rating

(30.09.2011)

India

A1

A1

 

Risk Category

ECGC Classification

Insignificant

 

A1

Low

 

A2

Moderate

 

B1

High

 

B2

Very High

 

C1

Restricted

 

C2

Off-credit

 

D

 

 

 

LOCATIONS

 

Registered Office :

Medley House, D-2, MIDC Area, 10th Road, Andheri (East), Mumbai – 400093, Maharashtra, India

Tel. No.:

91-22-28596815 / 30887777

Fax No.:

91-22-28590740 / 28204453

E-Mail :

sahir@medleylab.com

 

 

DIRECTORS

 

AS ON 22.09.2011

 

Name :

Mr. Sami Abdul Majid Khatib

Designation :

Director

Address :

Shoa, 25 Gulmohar Cross Road No.5, JVPD Schme, Vile Parle (West), Mumbai – 400049, Maharashtra, India

Date of Birth/Age :

07.07.1934

Date of Appointment :

12.08.1997

Date of Cessation :

14.11.2011

DIN No.:

00059442

 

 

Name :

Mr. Sarosh Sami Khatib

Designation :

Managing Director

Address :

Shoa, 25 Gulmohar Cross Road No.5, JVPD Schme, Vile Parle (West), Mumbai – 400049, Maharashtra, India

Date of Birth/Age :

21.02.1964

Date of Appointment :

12.08.1997

DIN No.:

00058143

 

Other Directorship:

 

S.No.

CIN

Name of the Company

Current designation of the director

Date of appointment at current designation

Original date of appointment

Date of cessation

Company Status

Defaulting status

1

U24230MH1975PLC018296

MEDLEY PHARMACEUTICALS LIMITED

Managing director

01-08-10

17-07-87

-

Active

NO

2

U33110MH1997PTC110023

STERANCO HEALTHCARE PRIVATE LIMITED

Managing director

12-08-97

12-08-97

-

Active

NO

3

U15139MH2008PTC188502

BLUE-FIN FROZEN FOODS PRIVATE LIMITED

Director

28-11-08

28-11-08

12-10-10

Active

NO

4

U24100MH1975PTC018500

MEDLEY LABORATORIES PRIVATE LIMITED

Director

25-09-09

09-02-09

-

Amalgamated

NO

5

U27200MH1983PTC031093

STANDARD PRECIOUS ALLOY INDUSTRIES PRIVATE LIMITED

Nominee director

01-11-11

01-11-11

-

Active

NO

6

U19100MH1988PTC048692

SINKHAI LEATHERS PRIVATE LIMITED

Director

09-11-11

09-11-11

-

Active

NO

 

 

Name :

Mr. Sahir Sami Khatib

Designation :

Director

Address :

Shoa, 25 Gulmohar Cross Road No.5, JVPD Schme, Vile Parle (West), Mumbai – 400049, Maharashtra, India

Date of Birth/Age :

26.10.1962

Date of Appointment :

01.09.1998

DIN No.:

00043681

 

Other Directorship:

 

S.No.

CIN

Name of the Company

Current designation of the director

Date of appointment at current designation

Original date of appointment

Date of cessation

Company Status

Defaulting status

1

U24110MH1983PTC030265

SORBO MONNI CHEMICALS PRIVATE LIMITED

Director

06-01-88

06-01-88

-

Active

NO

2

U19100MH1988PTC048692

SINKHAI LEATHERS PRIVATE LIMITED

Director

01-09-88

01-09-88

-

Active

NO

3

U24239MH1985PTC036869

MASIHA MEDICA PRIVATE LIMITED

Managing director

17-08-95

17-08-95

-

Active

NO

4

U65990MH1985PTC035944

SINKHAI INVESTMENTS PRIVATE LIMITED

Director

15-04-97

15-04-97

-

Active

NO

5

U33110MH1997PTC110023

STERANCO HEALTHCARE PRIVATE LIMITED

Director

01-09-98

01-09-98

-

Active

NO

6

U24230MH1975PLC018296

MEDLEY PHARMACEUTICALS LIMITED

Whole-time director

01-08-10

01-09-98

-

Active

NO

7

U24116MH1982PTC169259

MINAR CHEMICALS PRIVATE LIMITED

Director

14-08-00

14-08-00

-

Active

NO

8

U24230MH2005PLC151938

SINKHAI HEALTHCARE LIMITED

Director

14-03-05

14-03-05

-

Active

NO

9

U24230MH1997PTC106012

ORYX FISHERIES PRIVATE LIMITED

Director

28-09-06

28-09-06

-

Active

NO

10

U24239MH1979PTC021754

VIVOMED LABORATORIES PRIVATE LIMITED

Additional director

27-01-09

27-01-09

-

Active

NO

11

U24100MH1975PTC018500

MEDLEY LABORATORIES PRIVATE LIMITED

Director

25-09-09

09-02-09

-

Amalgamated

NO

12

U15139MH2008PTC188502

BLUE-FIN FROZEN FOODS PRIVATE LIMITED

Director

23-08-10

15-06-10

-

Active

NO

13

U27200MH1983PTC031093

STANDARD PRECIOUS ALLOY INDUSTRIES PRIVATE LIMITED

Nominee director

01-11-11

01-11-11

-

Active

NO

14

U24110MH1979PTC021755

SINKHAI SYNTHETICS AND CHEMICALS PRIVATE LIMITED

Director

09-11-11

09-11-11

20-12-11

Active

NO

15

U24230MH1986PTC039071

BIOGEN LABORATORIES (INDIA) PRIVATE LIMITED

Director

09-11-11

09-11-11

-

Active

NO

 

 

Name :

Mr. Farah Sarosh Khatib

Designation :

Director

Address :

Shoa, 25 Gulmohar Cross Road No.5, JVPD Schme, Vile Parle (West), Mumbai – 400049, Maharashtra, India

Date of Birth/Age :

13.07.1967

Date of Appointment :

01.09.1998

DIN No.:

00058106

 

Other Directorship:

 

S.No.

CIN

Name of the Company

Current designation of the director

Date of appointment at current designation

Original date of appointment

Date of cessation

Company Status

Defaulting status

1

U33110MH1997PTC110023

STERANCO HEALTHCARE PRIVATE LIMITED

Director

01-09-98

01-09-98

-

Active

NO

2

U15139MH2008PTC188502

BLUE-FIN FROZEN FOODS PRIVATE LIMITED

Director

28-11-08

28-11-08

13-08-10

Active

NO

 

MAJOR SHAREHOLDERS / SHAREHOLDING PATTERN

 

AS ON 22.09.2011

 

Names of Shareholders

No. of Shares

Sami Abdulmajid Khatib

10

Sarosh Sami Khatib

699990

Total

700000

 

AS ON 22.09.2011

 

Equity Shares Break Up

Percentage

Directors or relatives of Directors

100.00

Total

100.00

 

 

BUSINESS DETAILS

 

Line of Business :

Supplier of Pharmaceutical Formulations

 

 

GENERAL INFORMATION

 

No. of Employees :

Not Available

 

 

Bankers :

·         State Bank of India, MIDC, Andheri(E) Branch, Plot No.B-1, Central Road, Andheri (East), Mumbai - 400093, Maharashtra, India

 

 

Facilities :

Secured Loan

 

Rs. In Millions

31.03.2011

Rs. In Millions

31.03.2010

Overdraft with State Bank of India

 

 

(Secured against Personal Guarantee of Director)

1.472

0.000

 

 

 

Total

1.472

0.000

 

 

 

Unsecured Loan

 

Rs. In Millions

31.03.2011

Rs. In Millions

31.03.2010

From Directors

30.890

23.790

From Corporate Bodies

5.041

27.479

 

 

 

Total

35.931

51.269

 

 

 

Banking Relations :

--

 

 

Auditors :

 

Name :

RMJ and Associates

Chartered Accountant

Address :

3/1109R, Navjivan Society, Lamington Road, Mumbai Central, Mumbai – 400008, Maharashtra, India

Pan No.:

AAAFD1615J

 

 

CAPITAL STRUCTURE

 

AS ON 31.03.2011

 

Authorised Capital :

 

No. of Shares

Type

Value

Amount

 

 

 

 

700000

Equity Shares

Rs.10/- each

Rs. 7.000 Millions

 

 

 

 

 

Issued, Subscribed & Paid-up Capital :

 

No. of Shares

Type

Value

Amount

 

 

 

 

700000

Equity Shares

Rs.10/- each

Rs. 7.000 Millions

 

 

 

 

 


 

FINANCIAL DATA

[all figures are in Rupees Millions]

 

ABRIDGED BALANCE SHEET

 

SOURCES OF FUNDS

 

31.03.2011

31.03.2010

31.03.2009

SHAREHOLDERS FUNDS

 

 

 

1] Share Capital

7.000

2.000

2.000

2] Share Application Money

0.000

0.000

0.000

3] Reserves & Surplus

0.000

0.000

0.000

4] (Accumulated Losses)

(9.669)

(10.045)

(10.690)

NETWORTH

(2.669)

(8.045)

(8.690)

LOAN FUNDS

 

 

 

1] Secured Loans

1.472

0.000

0.000

2] Unsecured Loans

35.931

51.269

56.605

TOTAL BORROWING

37.403

51.269

56.605

DEFERRED TAX LIABILITIES

0.000

0.000

0.000

 

 

 

 

TOTAL

34.734

43.224

47.915

 

 

 

 

APPLICATION OF FUNDS

 

 

 

 

 

 

 

FIXED ASSETS [Net Block]

3.821

4.255

5.024

Capital work-in-progress

0.000

0.000

0.000

 

 

 

 

INVESTMENT

0.000

0.000

0.000

DEFERREX TAX ASSETS

1.886

2.493

3.271

 

 

 

 

CURRENT ASSETS, LOANS & ADVANCES

 

 

 

 

Inventories

11.897
7.628

12.042

 

Sundry Debtors

20.842
24.027

36.878

 

Cash & Bank Balances

0.276
4.055

3.518

 

Other Current Assets

0.000
0.000

0.000

 

Loans & Advances

3.122
4.927

5.689

Total Current Assets

36.137

40.637

58.127

Less : CURRENT LIABILITIES & PROVISIONS

 

 

 

 

Sundry Creditors

4.889
1.475

13.906

 

Other Current Liabilities

1.141
1.065

0.966

 

Provisions

1.080
1.621

3.635

Total Current Liabilities

7.110

4.161

18.507

Net Current Assets

29.027
36.476

39.620

 

 

 

 

MISCELLANEOUS EXPENSES

0.000

0.000

0.000

 

 

 

 

TOTAL

34.734

43.224

47.915

 

PROFIT & LOSS ACCOUNT

 

 

PARTICULARS

31.03.2011

31.03.2010

31.03.2009

 

SALES

 

 

 

 

Income

41.598

53.629

63.379

 

 

Other Income

1.241

0.802

 

 

 

TOTAL                                     (A)

42.839

54.431

63.379

 

 

 

 

 

Less

EXPENSES

 

 

 

 

 

Cost of Goods sold

29.186

40.797

61.808

 

 

Employees Cost

3.339

2.802

 

 

 

Operating Expenses

7.672

8.321

 

 

 

TOTAL                                     (B)

40.197

51.920

61.808

 

 

 

 

[Including

Less

PROFIT BEFORE INTEREST, TAX, DEPRECIATION AND AMORTISATION (A-B)      (C)

2.642

2.511

Financial

Expenses]

 

 

 

 

 

Less

FINANCIAL EXPENSES                         (D)

0.538

0.325

 

 

 

 

 

 

 

PROFIT BEFORE TAX, DEPRECIATION AND AMORTISATION (C-D)                                       (E)

2.104

2.186

1.571

 

 

 

 

 

Less/ Add

DEPRECIATION/ AMORTISATION                     (F)

0.567

0.739

0.815

 

 

 

 

 

 

PROFIT BEFORE TAX (E-F)                               (G)

1.537

1.447

0.756

 

 

 

 

 

Less

TAX                                                                  (H)

1.129

0.815

(3.073)

 

 

 

 

 

 

PROFIT AFTER TAX (G-H)                                (I)

0.408

0.632

3.829

 

 

 

 

 

Less/ Add

Prior Period Adjustments

(0.033)

0.014

0.000

 

 

 

 

 

 

PREVIOUS YEARS’ BALANCE BROUGHT FORWARD

(17.859)

(18.505)

(22.334)

 

 

 

 

 

 

BALANCE CARRIED TO THE B/S

(17.484)

(17.859)

(18.505)

 

 

 

 

 

 

EARNINGS IN FOREIGN CURRENCY

 

 

 

 

 

Export Earnings

10.287

15.274

NA

 

 

Commission Earnings

0.805

0.478

NA

 

TOTAL EARNINGS

11.092

15.752

NA

 

 

 

 

 

 

IMPORTS VALUE

26.636

35.325

NA

 

 

 

 

 

 

Earnings Per Share (Rs.)

0.58

--

--

 

 

 

KEY RATIOS

 

PARTICULARS

 

 

31.03.2011

31.03.2010

31.03.2009

PAT / Total Income

(%)

0.95

1.16

6.04

 

 

 

 

 

Net Profit Margin

(PBT/Sales)

(%)

3.69

2.70

NA

 

 

 

 

 

Return on Total Assets

(PBT/Total Assets}

(%)

3.67

3.05

1.20

 

 

 

 

 

Return on Investment (ROI)

(PBT/Networth)

 

(0.58)

(0.18)

(0.08)

 

 

 

 

 

Debt Equity Ratio

(Total Liability/Networth)

 

(16.68)

(6.89)

(8.64)

 

 

 

 

 

Current Ratio

(Current Asset/Current Liability)

 

5.08

9.77

3.14

 

 

LOCAL AGENCY FURTHER INFORMATION

 

OPERATIONS:

 

Sales for the year amounted to Rs.41.597 Millions as compared the previous year amounting to Rs. 53.629 Millions.

 

 

FORM 8

 

Corporate identity number of the company

U33110MH1997PTC110023

Name of the company

STERANCO HEALTHCARE PRIVATE LIMITED

Address of the registered office or of the principal place of  business in India of the company

Medley  House D2 Midc Areaarea 10 Th Road, Andheri East, Mumbai – 400093, Maharashtra, India

 

This form is for

Creation of charge

Type of charge

Book Debts

Movable Property

Immovable Property

Particular of charge holder

State Bank of India, MIDC, Andheri(E) Branch, Plot No.B-1, Central Road, Andheri(East),, Mumbai - 400093, Maharashtra, India

Nature of instrument creating charge

A. Agreement of Loan Cum Hypothecation (Sme-2)

B. No Instrument.  Memorandum For Recording Creation of Mortgage By Deposit of Title Deeds (Sme-5)

Both Constitute A Single Charge.

Date of instrument Creating the charge

19.03.2010

Amount secured by the charge

Rs.12.700 Millions

Brief of the principal terms an conditions and extent and operation of the charge

Rate of Interest

11.75% P.A.

 

Terms of Repayment

As Per Sanction Terms And Conditions

 

Margin

Letter Of Credit :20% *

Bank Guarantee : 20% *

*(Margin To Be Brought Upfront)

 

Others

Letter Of Credit                    10.000 Millions

Bank Guarantee                   2.500 Millions

Forward Contract Limit*       0.200 Millions

                                            ----------------------

              Total                       12.700 Millions

                                                         =============

 * 2% Of Forward Contract Limit Of Rs.10.000 Millions.

Short particulars of the property charged

All Present And Future Stocks, Raw Materials, Goods, Bookdebts And Vehicles And All Other Movable Assets of The Borrower Including Receivables, Documents of Title To Goods, Outstanding Monies, Bill Invoices Documents, Contracts, Insurance Policies, Guarantees, Engagements, Securities, Investments And Rights And The Present Machinery.

 

Company Offered Security By Way of An Equitable Mortgage By Deposit Of Title Deeds Over The Immovable Property To Secure Its Credit Facilities of Rs.12.700 Millions. The Details of Immovable Property Described As Per Annexure: Industrial Unit Bearing No.A-24, Admeasuring Area of 819 Sq. Ft. Approximately (Carpet Area) Situated on 2nd Floor In 'A' Wing of The Building, Known As 'Marol Nand Udyog Premises Co- Operative Society Limited.' Situated At Agnishamandal Marg, Marol Maroshi Road, Andheri (East), Mumbai-400059 Constructed on The Piece And Parcel Of Non Agriculture Land Bearing Survey No.61, Hissa No.1 of Village Marol, Taluka Andheri and District Mumbai Suburbs With The  Registration Districts And Sub District of Mumbai Suburban District And Within The Local Limits of Municipal Corporation of Greater Mumbai. Share Certificate: original Share Certificate No.540 With Distinctive Nos.101 To 105 Dated 1.4.1995 And Share Certificate No.541 With Distinctive Nos.971 To 975 Dated 1.4.1995 Issued By Co-operative Housing Society Limited (Duly Transferred In The Name of The Borrowers)

 

FIXED ASSETS:

 

  • Building
  • Surgical Equipments\Motor Car
  • Computers
  • Air Conditioner
  • Furniture and Fixtures
  • Office Equipments
  • Machinery

 

 

 


CMT REPORT (Corruption, Money Laundering & Terrorism]

 

The Public Notice information has been collected from various sources including but not limited to: The Courts, India Prisons Service, Interpol, etc.

 

1]         INFORMATION ON DESIGNATED PARTY

No records exist designating subject or any of its beneficial owners, controlling shareholders or senior officers as terrorist or terrorist organization or whom notice had been received that all financial transactions involving their assets have been blocked or convicted, found guilty or against whom a judgement or order had been entered in a proceedings for violating money-laundering, anti-corruption or bribery or international economic or anti-terrorism sanction laws or whose assets were seized, blocked, frozen or ordered forfeited for violation of money laundering or international anti-terrorism laws.

 

2]         Court Declaration :

No records exist to suggest that subject is or was the subject of any formal or informal allegations, prosecutions or other official proceeding for making any prohibited payments or other improper payments to government officials for engaging in prohibited transactions or with designated parties.

 

3]         Asset Declaration :

No records exist to suggest that the property or assets of the subject are derived from criminal conduct or a prohibited transaction.

 

4]         Record on Financial Crime :

            Charges or conviction registered against subject:                                                  None

 

5]         Records on Violation of Anti-Corruption Laws :

            Charges or investigation registered against subject:                                                          None

 

6]         Records on Int’l Anti-Money Laundering Laws/Standards :

            Charges or investigation registered against subject:                                                          None

 

7]         Criminal Records

No available information exist that suggest that subject or any of its principals have been formally charged or convicted by a competent governmental authority for any financial crime or under any formal investigation by a competent government authority for any violation of anti-corruption laws or international anti-money laundering laws or standard.

 

8]         Affiliation with Government :

No record exists to suggest that any director or indirect owners, controlling shareholders, director, officer or employee of the company is a government official or a family member or close business associate of a Government official.

 

9]         Compensation Package :

Our market survey revealed that the amount of compensation sought by the subject is fair and reasonable and comparable to compensation paid to others for similar services.

 

10]        Press Report :

            No press reports / filings exists on the subject.

 


 

CORPORATE GOVERNANCE

 

MIRA INFORM as part of its Due Diligence do provide comments on Corporate Governance to identify management and governance. These factors often have been predictive and in some cases have created vulnerabilities to credit deterioration.

 

Our Governance Assessment focuses principally on the interactions between a company’s management, its Board of Directors, Shareholders and other financial stakeholders.

 

 

CONTRAVENTION

 

Subject is not known to have contravened any existing local laws, regulations or policies that prohibit, restrict or otherwise affect the terms and conditions that could be included in the agreement with the subject.

 

 

FOREIGN EXCHANGE RATES

 

Currency

Unit

Indian Rupees

US Dollar

1

Rs. 50.59

UK Pound

1

Rs. 80.34

Euro

1

Rs. 67.13

 


 

SCORE & RATING EXPLANATIONS

 

SCORE FACTORS

 

RANGE

POINTS

HISTORY

1~10

5

PAID-UP CAPITAL

1~10

3

OPERATING SCALE

1~10

3

FINANCIAL CONDITION

 

 

--BUSINESS SCALE

1~10

3

--PROFITABILIRY

1~10

2

--LIQUIDITY

1~10

2

--LEVERAGE

1~10

2

--RESERVES

1~10

1

--CREDIT LINES

1~10

2

--MARGINS

-5~5

--

DEMERIT POINTS

 

 

--BANK CHARGES

YES/NO

YES

--LITIGATION

YES/NO

NO

--OTHER ADVERSE INFORMATION

YES/NO

NO

MERIT POINTS

 

 

--SOLE DISTRIBUTORSHIP

YES/NO

NO

--EXPORT ACTIVITIES

YES/NO

NO

--AFFILIATION

YES/NO

NO

--LISTED

YES/NO

NO

--OTHER MERIT FACTORS

YES/NO

YES

TOTAL

 

23

 

This score serves as a reference to assess SC’s credit risk and to set the amount of credit to be extended. It is calculated from a composite of weighted scores obtained from each of the major sections of this report. The assessed factors and their relative weights (as indicated through %) are as follows:

 

Financial condition (40%)            Ownership background (20%)                 Payment record (10%)

Credit history (10%)                    Market trend (10%)                                Operational size (10%)

 


 

RATING EXPLANATIONS

 

 

RATING

STATUS

 

 

PROPOSED CREDIT LINE

>86

Aaa

Possesses an extremely sound financial base with the strongest capability for timely payment of interest and principal sums

 

Unlimited

71-85

Aa

Possesses adequate working capital. No caution needed for credit transaction. It has above average (strong) capability for payment of interest and principal sums

 

Large

56-70

A

Financial & operational base are regarded healthy. General unfavourable factors will not cause fatal effect. Satisfactory capability for payment of interest and principal sums

 

Fairly Large

41-55

Ba

Overall operation is considered normal. Capable to meet normal commitments.

 

Satisfactory

26-40

B

Capability to overcome financial difficulties seems comparatively below average.

 

Small

11-25

Ca

Adverse factors are apparent. Repayment of interest and principal sums in default or expected to be in default upon maturity

 

Limited with full security

<10

C

Absolute credit risk exists. Caution needed to be exercised

 

 

Credit not recommended

-

NB

                                       New Business

-

 

 

 

 

 

PRIVATE & CONFIDENTIAL : This information is provided to you at your request, you having employed MIPL for such purpose. You will use the information as aid only in determining the propriety of giving credit and generally as an aid to your business and for no other purpose. You will hold the information in strict confidence, and shall not reveal it or make it known to the subject persons, firms or corporations or to any other. MIPL does not warrant the correctness of the information as you hold it free of any liability whatsoever. You will be liable to and indemnify MIPL for any loss, damage or expense, occasioned by your breach or non observance of any one, or more of these conditions

This report is issued at your request without any risk and responsibility on the part of MIRA INFORM PRIVATE LIMITED (MIPL) or its officials.